ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8,801 | 79.33698 | 1 | female | 0 | 21 | 109 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 9 | 24,248 | 16,439.4375 | 15,007.7578 | 16 | white | 28.699219 | 43 | 0.625 | 0.439941 | 1 | 1 | 0 | no | 0.05 | 0.02 | no dnr | 21 | 64 | 12.798828 | 77 | 28 | 36.5 | 174.28125 | 3.299805 | 0.299988 | 1.299805 | 138 | 7.429688 | 264 | 30 | 2,110 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,802 | 49.96597 | 1 | male | 0 | 11 | 261 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 0 | under $11k | 26 | 14,104 | 9,735.3125 | 9,969.23438 | 23.5 | white | 30 | 32 | 0.684937 | 0.591919 | 1 | 0 | 0 | no | 1 | 0.8 | no dnr | 11 | 106 | 3.699707 | 79 | 28 | 38.09375 | 247.59375 | 4.199219 | 0.5 | 1 | 134 | 7.419922 | 92 | 4 | 4,425 | null | 7 | adl>=4 (>=5 if sur) | 7 |
8,803 | 78.22296 | 1 | male | 1 | 25 | 25 | Coma | Coma | 2 | null | null | 44 | 59,397 | 39,876.875 | 41,626.9062 | 31.25 | white | 35.296875 | 54 | 0.033997 | 0.015999 | 9 | 0 | 1 | no | null | null | dnr after sadm | 20 | 118 | 13.798828 | 69 | 40 | 37.89844 | 82.84375 | null | 0.699951 | 0.799927 | 140 | 7.379883 | 262 | 37 | null | null | null | <2 mo. follow-up | 4.991211 |
8,804 | 64.18896 | 0 | female | 0 | 9 | 676 | Lung Cancer | Cancer | 4 | 12 | $11-$25k | 0 | 10,001 | 6,335.3242 | 6,368.84766 | 14 | white | 18.597656 | 12 | 0.67688 | 0.379944 | 1 | 0 | 0 | metastatic | 0.95 | 0.95 | no dnr | 9 | 105 | 31.5 | 70 | 22 | 36.29688 | 261.1875 | null | 0.899902 | 2.899902 | 136 | 7.459961 | 184 | 69 | 1,860 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,805 | 73.73297 | 0 | female | 0 | 12 | 675 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | under $11k | 0 | 13,660 | 9,851.0547 | 8,176.41797 | 28 | white | 36.195313 | 69 | 0.504883 | 0.387939 | 1 | 1 | 0 | no | 0.6 | 0.5 | no dnr | 12 | 112 | null | 69 | 24 | 35.79688 | null | null | null | 1.599854 | 138 | null | 75 | 38 | 2,600 | 6 | 2 | SIP>=30 | 2 |
8,806 | 58.47198 | 1 | female | 0 | 13 | 80 | Lung Cancer | Cancer | 1 | 9 | under $11k | 0 | 16,624 | 10,855.6016 | 11,437.0078 | 9.5 | white | 15.398438 | 6 | 0.75293 | 0.494995 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 13 | 83 | 20.597656 | 67 | 20 | 35.39844 | null | 4.199219 | 0.399963 | 1.5 | 140 | null | 126 | 27 | 1,400 | 2 | 3 | adl>=4 (>=5 if sur) | 3 |
8,807 | 65.659 | 1 | female | 0 | 5 | 224 | Lung Cancer | Cancer | 3 | 8 | under $11k | 0 | 3,161 | 2,090.9981 | 2,328.34961 | 5 | white | 12.199219 | 18 | 0.790894 | 0.559937 | 1 | 0 | 0 | metastatic | 0.4 | 0.2 | dnr after sadm | 1 | 115 | 17.296875 | 115 | 10 | 38.5 | 320 | null | null | 0.799927 | 134 | 7.509766 | 155 | 12 | 1,500 | 5 | 5 | null | 5 |
8,808 | 57.65598 | 1 | male | 0 | 19 | 120 | Lung Cancer | Cancer | 2 | 10 | null | 0 | 26,969 | 18,235.4688 | 19,058.5156 | 3.333332 | white | 19.097656 | 14 | 0.682983 | 0.388977 | 1 | 0 | 0 | metastatic | 1 | 0.51 | no dnr | 19 | 72 | 5.699219 | 101 | 30 | 38.59375 | null | 3.799805 | 0.599976 | 0.899902 | 131 | null | 179 | 12 | null | 0 | 0 | SIP>=30 | 0 |
8,809 | 65.90796 | 1 | male | 0 | 5 | 406 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 2,496 | 1,644.8779 | 1,368.30957 | 10 | white | 19.398438 | 40 | 0.86499 | 0.776978 | 1 | 1 | 0 | no | 0.8 | 0.5 | no dnr | 5 | 61 | 6.099609 | 51 | 32 | 35.59375 | 485.6875 | null | null | 1.299805 | 132 | 7.449219 | 96 | 64 | 2,200 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,810 | 52.87097 | 1 | male | 0 | 19 | 38 | MOSF w/Malig | ARF/MOSF | 0 | 12 | null | 0 | 36,129 | 25,131.2344 | 28,057.5469 | 21.333328 | white | 21.296875 | 35 | 0.712891 | 0.625977 | 6 | 0 | 0 | yes | 0.25 | 0.05 | no dnr | 19 | 99 | 10.199219 | 81 | 22 | 36.09375 | 247.59375 | null | 0.199982 | 1.299805 | 134 | 7.429688 | 83 | 23 | null | null | 0 | <2 mo. follow-up | 0 |
8,811 | 72.77496 | 1 | male | 0 | 7 | 548 | CHF | COPD/CHF/Cirrhosis | 5 | 9 | null | 0 | 5,221 | 3,341.7441 | 3,229.06836 | 5.5 | white | 16.097656 | 30 | 0.878906 | 0.79895 | 1 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 7 | 73 | 10.298828 | 60 | 24 | 35.59375 | 244 | 3.399902 | 0.899902 | 1.099854 | 134 | 7.519531 | 130 | 15 | 2,450 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,812 | 57.44299 | 0 | female | 0 | 6 | 668 | COPD | COPD/CHF/Cirrhosis | 1 | 8 | under $11k | 0 | 7,868 | 5,170.9336 | 5,612.03906 | 20 | white | 31 | 35 | 0.760986 | 0.620972 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 6 | 103 | 6.299805 | 65 | 32 | 35.89844 | 276.1875 | 3.099609 | 0.299988 | 1.299805 | 141 | 7.40918 | 101 | 32 | 1,925 | 0 | 1 | no(M2 and SIP pres) | 1 |
8,813 | 59.20599 | 1 | male | 1 | 7 | 7 | Coma | Coma | 0 | 12 | $25-$50k | 61 | 17,033 | 12,977.8281 | 14,498.8125 | 18 | white | 24.898438 | 40 | 0.440979 | 0.366943 | 1 | 0 | 0 | no | 0.3 | 0.25 | dnr after sadm | 6 | 70 | 11.898438 | 130 | 40 | 38 | 86.65625 | 3.899902 | 0.699951 | 1 | 143 | 7.40918 | 181 | 27 | 3,225 | null | 0 | <2 mo. follow-up | 0 |
8,814 | 58.94897 | 0 | male | 0 | 5 | 667 | COPD | COPD/CHF/Cirrhosis | 4 | 13 | $11-$25k | 0 | 3,548 | 2,230.9492 | 2,404.69922 | 10 | white | 12.898438 | 22 | 0.918945 | 0.862915 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 5 | 49 | 18.097656 | 60 | 24 | 38.39844 | 190 | 1.299805 | 0.699951 | 0.599976 | 132 | 7.349609 | 184 | 5 | 825 | 1 | null | no(M2 and SIP pres) | 1.166748 |
8,815 | 45.53299 | 0 | male | 0 | 10 | 664 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 13 | null | 0 | 9,094 | 6,265.3672 | 6,837.56641 | 14 | white | 26.296875 | 35 | 0.776978 | 0.643921 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 10 | 101 | 12.599609 | 81 | 24 | 36.69531 | null | null | 0.399963 | 2.399902 | 134 | null | 210 | 44 | 2,250 | 1 | 0 | no(M2 and SIP pres) | 0 |
8,816 | 67.85199 | 1 | male | 0 | 5 | 59 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 4,016 | 2,785.1367 | 3,827.56836 | 21 | white | 18.597656 | 23 | 0.832886 | 0.726929 | 1 | 0 | 0 | yes | 0.7 | 0.6 | dnr after sadm | 4 | 65 | 8 | 48 | 20 | 35.59375 | null | 4.099609 | 1.199951 | 1 | 134 | null | 104 | 8 | null | 0 | 0 | <2 mo. follow-up | 0 |
8,817 | 68.98596 | 1 | male | 0 | 5 | 279 | Colon Cancer | Cancer | 1 | 13 | $11-$25k | 0 | 2,823 | 1,840.5918 | 1,823.93945 | 8 | white | 11.599609 | 13 | 0.871948 | 0.712891 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 5 | 110 | 3.699707 | 76 | 24 | 38.19531 | null | null | null | 1.699951 | 131 | null | 245 | 25 | 1,785 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,818 | 41.64499 | 0 | male | 0 | 20 | 661 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $11-$25k | 0 | 28,886 | 19,517.5781 | 20,677.8281 | 28.333328 | white | 23.5 | 48 | 0.87793 | 0.834961 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 20 | 65 | 14.5 | 119 | 24 | 36.19531 | 209.5 | 3.399902 | 0.599976 | 0.899902 | 138 | 7.429688 | 115 | 20 | 600 | null | 0 | no(M2 and SIP pres) | 0 |
8,819 | 71.41095 | 1 | female | 0 | 13 | 77 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 10,856 | 7,223.6719 | 7,333.58984 | 9 | white | 16.097656 | 47 | 0.875977 | 0.793945 | 1 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 2 | 62 | null | 81 | 20 | 37 | null | null | null | 0.699951 | 141 | null | 129 | 8 | 2,075 | 2 | 3 | adl>=4 (>=5 if sur) | 3 |
8,820 | 54.12997 | 1 | female | 0 | 13 | 527 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 13 | under $11k | 0 | 29,479 | 20,409.8906 | 20,370.3906 | 27 | white | 28.699219 | 67 | 0.760986 | 0.68396 | 2 | 1 | 0 | no | 0.85 | 0.75 | no dnr | 13 | 108 | 8.099609 | 79 | 20 | 35.39844 | null | 3.399902 | 0.699951 | 1 | 134 | null | 111 | 19 | 3,175 | 6 | 5 | SIP>=30 | 5 |
8,821 | 64.99097 | 0 | male | 0 | 5 | 657 | Colon Cancer | Cancer | 1 | 12 | >$50k | 0 | 3,960 | 2,424.6211 | 1,743.30957 | 6 | white | 16.796875 | 7 | 0.819946 | 0.611938 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 5 | 59 | 10.099609 | 135 | 40 | 35.69531 | null | 3.799805 | 0.799927 | 1.5 | 124 | null | 171 | 40 | 3,775 | 1 | null | no(M2 and SIP pres) | 1.166748 |
8,822 | 46.56497 | 0 | male | 0 | 5 | 657 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 8,909 | 6,108.7539 | 6,189.33984 | 11 | white | 15.199219 | 15 | 0.928955 | 0.902954 | 1 | 0 | 0 | no | 0.99 | 0.95 | no dnr | 5 | 118 | 9.699219 | 60 | 10 | 37.79688 | 144 | 2.5 | 0.399963 | 1 | 134 | 7.5 | 126 | 11 | 2,650 | null | null | null | 2.746094 |
8,823 | 78.54297 | 1 | male | 0 | 6 | 275 | Colon Cancer | Cancer | 2 | null | null | 0 | 4,668 | 2,988.3613 | 3,181.37891 | 13 | white | 19 | 12 | 0.758911 | 0.503906 | 1 | 0 | 0 | metastatic | 0.9 | 0.75 | dnr before sadm | -1 | 107 | 12.099609 | 117 | 10 | 37.89844 | 217.5 | null | null | 0.899902 | 149 | 7.40918 | 164 | 51 | 2,580 | 1 | null | null | 1.166748 |
8,824 | 77.55798 | 0 | male | 0 | 9 | 655 | CHF | COPD/CHF/Cirrhosis | 4 | 7 | $11-$25k | 0 | 7,842 | 5,684.3164 | 5,780.52734 | 9.5 | white | 37.195313 | 37 | 0.452942 | 0.250977 | 1 | 1 | 0 | no | null | null | no dnr | 9 | 79 | 8.298828 | 52 | 24 | 38.79688 | 390.4375 | null | 0.899902 | 4.299805 | 140 | 7.389648 | 110 | 67 | 1,950 | 1 | 0 | no(M2 and SIP pres) | 0 |
8,825 | 72.06598 | 0 | male | 0 | 16 | 655 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | $11-$25k | 0 | 30,235 | 19,548.6094 | 21,709.6406 | 19.666656 | white | 19.097656 | 26 | 0.779907 | 0.708984 | 4 | 0 | 0 | yes | 1 | 1 | no dnr | 16 | 108 | 20.898438 | 160 | 32 | 38.39844 | 287.75 | 3.299805 | 0.799927 | 0.799927 | 131 | 7.479492 | 110 | 15 | 3,950 | 1 | 0 | SIP>=30 | 0 |
8,826 | 69.37994 | 1 | male | 0 | 8 | 9 | Lung Cancer | Cancer | 1 | 8 | under $11k | 0 | 9,324 | 5,800.918 | 5,449.05859 | 13 | white | 19.796875 | 30 | 0.635986 | 0.325989 | 1 | 0 | 0 | metastatic | 1 | 0.6 | dnr after sadm | 1 | 72 | null | 70 | 28 | 35.59375 | null | 3.799805 | 0.699951 | 8.699219 | 134 | null | 99 | 56 | 0 | null | 0 | <2 mo. follow-up | 0 |
8,827 | 68.20294 | 1 | male | 0 | 15 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 46,267 | 45,581.8438 | 49,192.9375 | 49 | white | 23 | 41 | 0.761963 | 0.685913 | 8 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 14 | 64 | 21.5 | 36 | 32 | 37.89844 | 318 | 2.799805 | 0.899902 | 2.699707 | 132 | 7.279297 | 268 | 49 | 1,125 | null | 0 | <2 mo. follow-up | 0 |
8,828 | 52.22699 | 1 | male | 1 | 20 | 20 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 8 | null | 37 | 26,657 | 18,330.8281 | 20,138.2188 | 15.666664 | white | 19.296875 | 22 | 0.74292 | 0.594971 | 1 | 1 | 0 | no | null | null | dnr after sadm | 20 | 56 | 9.199219 | 160 | 40 | 38.29688 | 218.5 | null | null | 1.399902 | 132 | 7.469727 | 149 | 13 | 1,300 | null | 5 | <2 mo. follow-up | 5 |
8,829 | 57.59097 | 1 | male | 0 | 27 | 207 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 61 | 39,876 | 27,313.75 | 29,164.2031 | 28.75 | white | 21.796875 | 27 | 0.731934 | 0.579956 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 27 | 63 | 0.399963 | 130 | 40 | 39.59375 | 182.84375 | 2.899902 | 3 | 1.399902 | 140 | 7.439453 | 395 | 31 | 5,450 | null | 0 | SIP>=30 | 0 |
8,830 | 63.98898 | 1 | male | 1 | 5 | 5 | Lung Cancer | Cancer | 3 | null | null | 100 | 5,764 | 3,601 | 3,166.89844 | 29 | white | 30.296875 | 21 | 0.014999 | 0 | 1 | 0 | 0 | metastatic | 0.2 | 0.2 | dnr after sadm | 1 | 68 | 4.599609 | 39 | 22 | 35.89844 | 466.625 | null | 0.899902 | 1.199951 | 142 | 7.529297 | 132 | 26 | 1,850 | null | null | <2 mo. follow-up | 4.333008 |
8,831 | 83.31299 | 0 | male | 0 | 9 | 648 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | null | 9 | 11,919 | 8,023.8086 | 8,385.92969 | 24.5 | white | 22.296875 | 40 | 0.738892 | 0.656982 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 9 | 76 | 7 | 70 | 24 | 36.59375 | null | 4.599609 | 0.399963 | 1 | 137 | null | 114 | 5 | 1,975 | 1 | 0 | no(M2 and SIP pres) | 0 |
8,832 | 76.83197 | 0 | male | 0 | 7 | 647 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 9 | 3,917 | 2,545.1894 | 2,199.51953 | 5 | white | 17.796875 | 24 | 0.831909 | 0.725952 | 1 | 0 | 1 | no | 0.75 | 0.75 | dnr after sadm | 5 | 117 | 24.5 | 58 | 10 | 38.89844 | 154.53125 | 2.599609 | 24 | 5.899414 | 141 | 7.40918 | 118 | 81 | 30 | null | 6 | no(M2 and SIP pres) | 6 |
8,833 | 67.79999 | 1 | male | 0 | 8 | 12 | Coma | Coma | 1 | 14 | null | 100 | 28,580 | 18,889.2812 | 19,848.125 | 32.5 | white | 28.5 | 38 | 0.060997 | 0.032997 | 3 | 0 | 0 | no | 0.2 | 0.05 | dnr after sadm | 5 | 75 | 26.796875 | 118 | 20 | 35.29688 | 309.5 | null | 0.5 | 0.699951 | 137 | 7.449219 | 150 | 14 | 1,500 | null | 6 | <2 mo. follow-up | 6 |
8,834 | 58.59799 | 1 | female | 0 | 8 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 9 | 20,012 | 15,636.9688 | 16,694.8594 | 15.5 | white | 24.398438 | 53 | 0.748901 | 0.669922 | 8 | 0 | 0 | no | 0.25 | 0.1 | dnr after sadm | 8 | 66 | 3.5 | 79 | 26 | 38.69531 | 128.875 | 2.199707 | 1.299805 | 0.599976 | 156 | 7.459961 | 119 | 9 | 6,200 | null | null | <2 mo. follow-up | 2.768555 |
8,835 | 78.10498 | 0 | female | 0 | 5 | 644 | CHF | COPD/CHF/Cirrhosis | 3 | 5 | under $11k | 9 | 3,989 | 2,674.8652 | 2,562.94922 | 14 | white | 23.597656 | 26 | 0.738892 | 0.589966 | 1 | 0 | 1 | no | 0.7 | 0.5 | no dnr | 5 | 67 | 15.5 | 114 | 28 | 36.89844 | 112.5 | 4.099609 | 0.699951 | 3 | 132 | 7.489258 | 123 | 40 | 830 | null | null | no(M2 and SIP pres) | 5.21875 |
8,836 | 66.71899 | 1 | female | 0 | 20 | 370 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 40,797 | null | null | 12.666664 | white | 23.296875 | 35 | 0.645996 | 0.545898 | 1 | 1 | 0 | metastatic | 0.7 | 0.5 | no dnr | 20 | 76 | 7.399414 | 74 | 24 | 35.89844 | 222.71875 | 4 | 1.799805 | 1 | 142 | 7.319336 | 92 | 28 | 1,220 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,837 | 73.5 | 1 | male | 0 | 16 | 120 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 14,996 | 9,510.5469 | 9,354.44531 | 11.333328 | white | 6.299805 | 13 | 0.910889 | 0.793945 | 1 | 0 | 0 | metastatic | 0.8 | 0.75 | dnr after sadm | 1 | 63 | 13.5 | 132 | 28 | 39.29688 | 123.625 | 1.899902 | 1.099854 | 0.699951 | 139 | 7.419922 | 127 | 3 | 5,375 | null | 1 | no(M2 and SIP pres) | 1 |
8,838 | 71.77295 | 1 | male | 0 | 7 | 18 | COPD | COPD/CHF/Cirrhosis | 3 | 10 | null | 0 | 6,705 | 4,389.4414 | 3,861.16992 | 6 | white | 21.597656 | 36 | 0.810913 | 0.69397 | 1 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 7 | 59 | 7.5 | 79 | 16 | 36.19531 | null | 3.899902 | 0.199982 | 1.5 | 139 | null | 134 | 23 | null | 0 | 2 | <2 mo. follow-up | 2 |
8,839 | 82.93799 | 1 | female | 1 | 4 | 4 | COPD | COPD/CHF/Cirrhosis | 5 | 8 | under $11k | 26 | 6,338 | 4,364.4844 | 4,638.00781 | 22 | white | 24.597656 | 63 | 0.53894 | 0.339966 | 2 | 1 | 1 | no | 0.5 | 0 | dnr before sadm | -1 | 67 | 15.199219 | 128 | 30 | 34.39844 | 260 | 2.699707 | 0.299988 | 0.899902 | 135 | 7.479492 | 240 | 23 | 1,350 | null | null | <2 mo. follow-up | 5.993164 |
8,840 | 81.63995 | 1 | male | 0 | 38 | 345 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | null | 9 | 55,955 | 35,859.2188 | 40,620.4688 | 19.25 | white | 23.398438 | 64 | 0.670898 | 0.574951 | 6 | 0 | 0 | no | 0.5 | 0.125 | dnr after sadm | 8 | 137 | 13.599609 | 60 | 24 | 35.69531 | 369.5625 | null | null | 0.899902 | 130 | 7.319336 | 194 | 25 | 1,975 | null | 5 | SIP>=30 | 5 |
8,841 | 69.60999 | 1 | female | 0 | 32 | 34 | Coma | Coma | 3 | 12 | $11-$25k | 44 | 150,249 | 106,119.312 | 113,850.062 | 28.5 | white | 25.398438 | 48 | 0.266968 | 0.198975 | 40 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 26 | 117 | 11.099609 | 68 | 28 | 35.59375 | 160 | 2.299805 | 3.799805 | 0.899902 | 144 | 7.329102 | 256 | 25 | 5,550 | null | 0 | <2 mo. follow-up | 0 |
8,842 | 79.995 | 1 | female | 0 | 11 | 197 | COPD | COPD/CHF/Cirrhosis | 7 | 9 | $25-$50k | 9 | 8,495 | 5,334.9688 | 4,880.17969 | 9.5 | white | 26.296875 | 38 | 0.628906 | 0.445984 | 1 | 0 | 1 | no | 0.5 | 0.4 | dnr after sadm | 1 | 102 | 3.899902 | 63 | 24 | 35.79688 | null | null | null | 0.899902 | 139 | null | 100 | 9 | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
8,843 | 76.63196 | 0 | male | 0 | 18 | 639 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 10,375 | 6,827.0039 | 6,236.20703 | 7.333332 | white | 19.5 | 34 | 0.765991 | 0.628906 | 1 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 18 | 52 | 9.199219 | 118 | 24 | 35.79688 | null | null | 0.299988 | 0.899902 | 137 | null | 153 | 16 | null | null | 2 | no(M2 and SIP pres) | 2 |
8,844 | 72.61298 | 1 | male | 0 | 7 | 17 | Lung Cancer | Cancer | 2 | 8 | $11-$25k | 9 | 10,843 | 6,651.1914 | 4,538.21875 | 5 | white | 26.699219 | 16 | 0.394958 | 0.099991 | 1 | 0 | 0 | metastatic | 0.5 | 0.15 | dnr after sadm | 3 | 117 | 23.796875 | 60 | 14 | 38.69531 | 213.3125 | 3.299805 | 0.799927 | 4.399414 | 145 | 7.369141 | 299 | 67 | 1,081 | null | 0 | <2 mo. follow-up | 0 |
8,845 | 70.56494 | 0 | male | 0 | 4 | 635 | COPD | COPD/CHF/Cirrhosis | 1 | 13 | $25-$50k | 0 | 2,365 | 1,585.7607 | 1,604.69922 | 5 | white | 18.097656 | 20 | 0.859985 | 0.767944 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 4 | 73 | 5.399414 | 63 | 24 | 35.89844 | null | 3.099609 | 1.5 | 1.399902 | 128 | null | 218 | 30 | 4,275 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,846 | 74.70996 | 1 | male | 1 | 43 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 37 | 200,862 | 143,377.125 | 142,079.875 | 37.75 | white | 34.09375 | 46 | 0.243988 | 0.141998 | 21 | 0 | 0 | no | null | null | dnr after sadm | 35 | 51 | 9.798828 | 81 | 20 | 36.5 | 400 | 4 | 0.5 | 1.199951 | 134 | 7.459961 | 181 | 35 | 1,475 | null | 0 | <2 mo. follow-up | 0 |
8,847 | 69.47296 | 1 | female | 0 | 7 | 20 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 5,038 | 3,265.9492 | 3,421.63867 | 2 | white | 22.097656 | 39 | 0.816895 | 0.703979 | 1 | 0 | 0 | no | 0.9 | 0.8 | dnr after sadm | 1 | 43 | 8.898438 | 130 | 29 | 40.19531 | 300 | 2.599609 | 0.299988 | 0.599976 | 135 | 7.399414 | 138 | 6 | 1,550 | 1 | null | <2 mo. follow-up | 1.166748 |
8,848 | 65.487 | 1 | male | 0 | 7 | 28 | CHF | COPD/CHF/Cirrhosis | 2 | 7 | under $11k | 37 | 5,066 | 3,334.2227 | 3,096.9082 | 5 | white | 18.699219 | 24 | 0.793945 | 0.668945 | 1 | 0 | 0 | no | 0.8 | 0.512 | dnr after sadm | 3 | 58 | 9.699219 | 77 | 32 | 35.5 | null | null | null | 1.399902 | 136 | null | 108 | 41 | null | 0 | 0 | <2 mo. follow-up | 0 |
8,849 | 67.84399 | 1 | female | 1 | 12 | 12 | Coma | Coma | 0 | 16 | >$50k | 94 | 34,959 | 24,302.5469 | 26,362.4375 | 29 | white | 26.699219 | 33 | 0.082993 | 0.047997 | 7 | 0 | 0 | no | 0.24 | 0.24 | dnr after sadm | 5 | 75 | 17 | 105 | 25 | 38.09375 | 285.6875 | null | null | 0.699951 | 138 | 7.429688 | 112 | 6 | 3,975 | null | 0 | <2 mo. follow-up | 0 |
8,850 | 76.26794 | 0 | male | 0 | 9 | 634 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 26 | 8,633 | 5,600.3711 | 5,183.20703 | 14.5 | white | 27 | 33 | 0.494995 | 0.293945 | 1 | 0 | 0 | yes | null | null | dnr after sadm | 1 | 102 | 3.899902 | 110 | 10 | 36.79688 | 374.25 | 2.799805 | 0.199982 | 0.5 | 139 | 7.40918 | 121 | 6 | 2,125 | null | 1 | no(M2 and SIP pres) | 1 |
8,851 | 50.86099 | 0 | male | 0 | 7 | 634 | CHF | COPD/CHF/Cirrhosis | 5 | 14 | null | 0 | 3,603 | 2,394.8223 | 1,887.16992 | 4.5 | white | 31.296875 | 21 | 0.760986 | 0.620972 | 1 | 1 | 0 | no | null | null | dnr after sadm | 1 | 56 | 8.5 | 106 | 10 | 38.89844 | 135 | 2.299805 | 0.699951 | 5 | 127 | 7.399414 | 96 | 55 | 472 | 1 | 0 | SIP>=30 | 0 |
8,852 | 62.92398 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 100 | 58,428 | 38,707.1562 | 39,558.0312 | 47 | white | 44.195313 | 82 | 0.002 | 0 | 21 | 0 | 0 | no | 0 | 0 | dnr after sadm | 1 | 99 | 6.899414 | 126 | 18 | 36.29688 | null | 3.899902 | 0.799927 | 0.899902 | 140 | null | 116 | 14 | null | null | 1 | <2 mo. follow-up | 1 |
8,853 | 75.22198 | 0 | male | 0 | 15 | 633 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | null | 0 | 46,467 | 31,250.3906 | 32,330.6406 | 27.333328 | white | 25.398438 | 39 | 0.681885 | 0.587891 | 9 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 15 | 121 | 8.298828 | 70 | 16 | 36.09375 | 309.5 | 4.199219 | 0.399963 | 1.399902 | 140 | 7.449219 | 194 | 22 | 3,400 | null | 0 | no(M2 and SIP pres) | 0 |
8,854 | 90.36798 | 0 | female | 0 | 4 | 631 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 2,206 | 1,536.5508 | 1,430.35938 | 11 | white | 19.597656 | 36 | 0.775879 | 0.642944 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 4 | 75 | 8.099609 | 145 | 24 | 37.79688 | 230 | null | null | 1.199951 | 128 | 7.519531 | 166 | 20 | 1,570 | 1 | null | no(M2 and SIP pres) | 1.166748 |
8,855 | 79.27698 | 0 | male | 0 | 7 | 631 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 6,405 | 4,273.7734 | 4,210.89844 | 7.5 | white | 19.097656 | 39 | 0.826904 | 0.717896 | 1 | 1 | 0 | no | null | null | no dnr | 7 | 70 | 12.5 | 110 | 32 | 38.69531 | 125.45312 | 2.099609 | 5.5 | 1.199951 | 133 | 7.5 | 124 | 33 | 2,525 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,856 | 89.12 | 1 | male | 0 | 5 | 248 | CHF | COPD/CHF/Cirrhosis | 6 | 4 | null | 0 | 3,031 | 2,076.1348 | 2,175.12891 | 15 | white | 18.097656 | 20 | 0.803955 | 0.68396 | 1 | 1 | 1 | no | 0.8 | 0.7 | no dnr | 5 | 57 | 16.597656 | 134 | 12 | 37.5 | 285 | 3.099609 | 0.5 | 1.699951 | 137 | 7.449219 | 126 | 34 | 775 | null | 5 | adl>=4 (>=5 if sur) | 5 |
8,857 | 74.42798 | 1 | female | 0 | 10 | 102 | Colon Cancer | Cancer | 2 | 5 | under $11k | 0 | 7,917 | 5,127.7461 | 4,562.58984 | 13 | white | 12.599609 | 25 | 0.85498 | 0.678955 | 1 | 0 | 1 | metastatic | 0.05 | 0 | no dnr | 10 | 98 | 10.298828 | 77 | 24 | 35.69531 | 304 | null | 0.799927 | 0.899902 | 137 | 7.349609 | 334 | 17 | null | 1 | 0 | null | 0 |
8,858 | 63.97498 | 1 | male | 0 | 5 | 145 | Lung Cancer | Cancer | 2 | 12 | under $11k | 0 | 5,272 | 3,413.043 | 3,295.48828 | 10 | white | 18.199219 | 11 | 0.685913 | 0.392944 | 1 | 0 | 0 | metastatic | 0.7 | 0.1 | dnr after sadm | 1 | 59 | 6.599609 | 113 | 11 | 36.39844 | 100 | 2.5 | 9.5 | 1.399902 | 140 | 7.569336 | 108 | 31 | 3,470 | 0 | 2 | adl>=4 (>=5 if sur) | 2 |
8,859 | 73.28998 | 0 | female | 0 | 17 | 628 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 9 | 44,287 | 29,971.6406 | 30,189.6562 | 29.333328 | white | 35.59375 | 50 | 0.390991 | 0.271973 | 7 | 1 | 0 | no | 0.2 | 0.1 | dnr after sadm | 2 | 68 | 8.298828 | 120 | 20 | 36.39844 | null | 4.299805 | 0.399963 | 1.5 | 138 | null | 233 | 42 | 2,025 | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,860 | 21.63199 | 0 | female | 0 | 53 | 628 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | under $11k | 41 | 148,162 | 101,257.312 | 121,249.375 | 47 | white | 26.097656 | 38 | 0.819946 | 0.759888 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 53 | 66 | 17.199219 | 104 | 32 | 38.39844 | 165 | null | null | 1.5 | 133 | 7.479492 | 163 | 22 | null | null | 0 | no(M2 and SIP pres) | 0 |
8,861 | 72.435 | 0 | male | 0 | 25 | 627 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 74,657 | 49,330.9062 | 53,275.25 | 16.75 | white | 30.097656 | 42 | 0.48999 | 0.371948 | 16 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 25 | 96 | 5.699219 | 69 | 16 | 36.09375 | 323.75 | 4.099609 | 0.399963 | 1.199951 | 136 | 7.459961 | 115 | 6 | 1,450 | null | 0 | no(M2 and SIP pres) | 0 |
8,862 | 70.75195 | 1 | male | 0 | 5 | 240 | COPD | COPD/CHF/Cirrhosis | 5 | 8 | null | 0 | 3,427 | 2,172.2734 | 1,754.34961 | 9 | white | 30.796875 | 44 | 0.580933 | 0.387939 | 1 | 1 | 0 | yes | 0.9 | 0.8 | no dnr | 5 | 67 | 9.5 | 80 | 24 | 39.09375 | 257.5 | 2.099609 | 0.299988 | 1.699951 | 137 | 7.40918 | 82 | 40 | 775 | 1 | 0 | null | 0 |
8,863 | 83.71497 | 0 | female | 0 | 15 | 627 | MOSF w/Malig | ARF/MOSF | 2 | 8 | null | 0 | 35,843 | 24,067.2188 | 23,331.1875 | 28 | white | 22.5 | 43 | 0.563965 | 0.452942 | 7 | 0 | 0 | metastatic | 0.8 | 0.7 | no dnr | 15 | 62 | 18.898438 | 134 | 28 | 38.69531 | 136 | 1.699951 | 0.199982 | 0.899902 | 140 | 7.459961 | 206 | 16 | 1,325 | null | 0 | no(M2 and SIP pres) | 0 |
8,864 | 78.75696 | 1 | male | 0 | 9 | 536 | MOSF w/Malig | ARF/MOSF | 0 | 8 | null | 0 | 27,466 | 18,589.9375 | 18,974.4062 | 27.5 | white | 26.398438 | 40 | 0.547974 | 0.43396 | 7 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 9 | 70 | 12.798828 | 78 | 24 | 35.79688 | 362.9375 | null | 0.299988 | 1.099854 | 138 | 7.429688 | 278 | 18 | null | null | 0 | no(M2 and SIP pres) | 0 |
8,865 | 71.37897 | 1 | male | 0 | 6 | 26 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 3,740 | 2,478.7617 | 1,955.72949 | 9 | white | 16.699219 | 24 | 0.876953 | 0.794922 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 39 | 32.59375 | 130 | 10 | 36 | 152 | 3.199707 | 8.199219 | 5.199219 | 127 | 7.369141 | 212 | 105 | 75 | null | 0 | <2 mo. follow-up | 0 |
8,866 | 78.77594 | 1 | female | 0 | 6 | 557 | Cirrhosis | COPD/CHF/Cirrhosis | 6 | 8 | null | 0 | 4,257 | 2,828.1602 | 2,308.66992 | 11 | white | 16.398438 | 18 | 0.675903 | 0.505981 | 1 | 1 | 0 | yes | 0.5 | 0.25 | dnr after sadm | 1 | 74 | 4.899414 | 77 | 24 | 36.39844 | 260 | 2.199707 | 0.099991 | 0.899902 | 137 | 7.319336 | 141 | 17 | 3,210 | 1 | 1 | no(M2 and SIP pres) | 1 |
8,867 | 48.68698 | 0 | female | 0 | 109 | 623 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 13 | under $11k | 0 | 130,793 | 86,623.625 | 98,248.9375 | 34.25 | white | 31.296875 | 59 | 0.657959 | 0.480957 | 1 | 0 | 0 | no | null | null | dnr after sadm | 27 | 129 | 12.398438 | 85 | 22 | 36.5 | null | 3.899902 | 0.599976 | 1 | 135 | null | 148 | 27 | null | null | 0 | SIP>=30 | 0 |
8,868 | 74.17096 | 0 | male | 0 | 14 | 625 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 10,170 | 6,691.2109 | 6,019.69922 | 8 | white | 22.199219 | 46 | 0.787964 | 0.659912 | 1 | 0 | 0 | no | 0.4 | 0.4 | no dnr | 14 | 78 | 8.298828 | 53 | 16 | 35.89844 | null | null | null | 1.399902 | 138 | null | 124 | 18 | 3,100 | 2 | 0 | no(M2 and SIP pres) | 0 |
8,869 | 56.92798 | 1 | female | 1 | 10 | 10 | Lung Cancer | Cancer | 1 | 12 | null | 9 | 7,075 | 4,833.2344 | 4,892.78906 | 11 | white | 20.097656 | 11 | 0.626953 | 0.314941 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 4 | 117 | 9.298828 | 126 | 24 | 36.39844 | 224 | null | 0.599976 | 1.099854 | 135 | 7.449219 | 115 | 23 | 1,055 | null | 7 | <2 mo. follow-up | 7 |
8,870 | 69.54095 | 1 | male | 0 | 9 | 20 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 6,304 | 4,241.2578 | 3,871.61914 | 6 | white | 24 | 28 | 0.649902 | 0.470947 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 9 | 82 | 0.099991 | 148 | 22 | 36.09375 | null | null | null | 1.399902 | 145 | null | 155 | 39 | null | null | 3 | <2 mo. follow-up | 3 |
8,871 | 74.93994 | 0 | male | 0 | 9 | 621 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | $11-$25k | 9 | 48,671 | 31,515.9844 | 33,310.1562 | 24.5 | white | 25.398438 | 35 | 0.647949 | 0.547974 | 9 | 0 | 0 | no | null | null | no dnr | 9 | 79 | 12.099609 | 40 | 15 | 35.59375 | 355 | 3.599609 | 0.799927 | 1.199951 | 137 | 7.399414 | 146 | 25 | 1,000 | null | 0 | no(M2 and SIP pres) | 0 |
8,872 | 70.13794 | 1 | female | 0 | 3 | 194 | Lung Cancer | Cancer | 1 | 10 | null | 0 | 4,685 | 2,963.8652 | 3,459.82812 | null | white | 7.699219 | 12 | 0.843994 | 0.655884 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 65 | 12 | 79 | 24 | 36.09375 | 292 | null | 0.5 | 1.399902 | 134 | 7.389648 | 354 | 43 | 1,465 | null | null | no(M2 and SIP pres) | 1.722168 |
8,873 | 72.90295 | 0 | male | 0 | 10 | 620 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 23,344 | 16,110.2969 | 15,581.7188 | 41.5 | white | 26.296875 | 43 | 0.740967 | 0.659912 | 1 | 0 | 0 | no | null | null | dnr after sadm | 8 | 61 | 10.699219 | 140 | 24 | 38.09375 | 87.14062 | null | 0.299988 | 1.099854 | 129 | 7.369141 | 136 | 12 | 3,200 | null | 1 | SIP>=30 | 1 |
8,874 | 53.95798 | 0 | female | 0 | 28 | 619 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 26 | 30,829 | 17,709.4688 | 17,719.1094 | 11.5 | white | 27.296875 | 44 | 0.596924 | 0.406982 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 2 | 57 | 11.798828 | 88 | 30 | 39 | 182.5 | 3.099609 | 2.399902 | 1.199951 | 137 | 7.509766 | 152 | 15 | 1,424 | null | 6 | no(M2 and SIP pres) | 6 |
8,875 | 91.90997 | 1 | male | 0 | 10 | 175 | COPD | COPD/CHF/Cirrhosis | 5 | 16 | null | 0 | 13,204 | 8,966.2344 | 11,215.1875 | 16 | white | 32.5 | 56 | 0.360962 | 0.168976 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 1 | 70 | 0.899902 | 73 | 28 | 35.69531 | null | 2.699707 | 1.299805 | 1.799805 | 135 | null | 239 | 42 | 5,980 | 0 | null | no(M2 and SIP pres) | 0.494751 |
8,876 | 56.31998 | 0 | male | 0 | 6 | 618 | COPD | COPD/CHF/Cirrhosis | 3 | 16 | under $11k | 0 | 4,302 | 2,707.6777 | 2,766.57812 | 13 | white | 10.699219 | 32 | 0.921997 | 0.866943 | 1 | 0 | 0 | metastatic | 0.85 | 0.8 | no dnr | 6 | 127 | 12.798828 | 143 | 24 | 36.19531 | 110 | 3.699707 | 2 | 1.399902 | 135 | 7.189453 | 113 | 34 | 900 | null | null | no(M2 and SIP pres) | 2.581543 |
8,877 | 87.56696 | 0 | female | 0 | 14 | 617 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | null | 0 | 9,171 | 6,001.6445 | 5,309.58984 | 7.333332 | white | 17.199219 | 24 | 0.821899 | 0.710938 | 1 | 1 | 0 | no | null | null | dnr after sadm | 2 | 121 | 16.597656 | 58 | 32 | 37.89844 | 127.5 | 3.299805 | 0.599976 | 2.799805 | 133 | 7.379883 | 254 | 111 | 765 | null | 2 | no(M2 and SIP pres) | 2 |
8,878 | 54.13797 | 1 | male | 1 | 6 | 6 | Coma | Coma | 0 | 12 | $25-$50k | 100 | 13,290 | 9,129.0234 | 9,817.0625 | 40 | white | 26.199219 | 29 | 0.250977 | 0.184998 | 1 | 0 | 0 | no | 0.1 | 0.05 | dnr after sadm | 4 | 99 | 0.199982 | 115 | 30 | 39.19531 | null | 3 | null | 1.799805 | 146 | null | 139 | 41 | 2,800 | null | 0 | <2 mo. follow-up | 0 |
8,879 | 60.08499 | 1 | male | 0 | 6 | 80 | Lung Cancer | Cancer | 2 | 12 | >$50k | 0 | 6,801 | 4,314.7969 | 2,377.79883 | 12 | white | 17.296875 | 21 | 0.714966 | 0.434998 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 6 | 101 | 7.199219 | 70 | 22 | 37.29688 | 520 | null | null | 2.199707 | 140 | 7.349609 | 185 | 60 | 2,150 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,880 | 81.95496 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 22,645 | 15,302.2266 | 16,727.4688 | 42.5 | white | 28.699219 | 48 | 0.608887 | 0.50293 | 3 | 0 | 0 | no | 0.25 | 0.25 | dnr after sadm | 5 | 73 | 13.798828 | 61 | 20 | 36.79688 | null | null | null | 1 | 138 | null | 162 | 15 | 2,850 | null | 2 | <2 mo. follow-up | 2 |
8,881 | 70.94598 | 1 | male | 0 | 25 | 26 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 13 | $25-$50k | 100 | 68,567 | 47,417 | 56,280.75 | 25.75 | white | 31.796875 | 68 | 0.081985 | 0.030998 | 9 | 0 | 0 | no | null | null | dnr after sadm | 24 | 49 | 13.5 | 134 | 10 | 37.89844 | 215 | 3.399902 | 0.299988 | 1.5 | 137 | 7.449219 | 238 | 30 | 1,650 | null | 0 | <2 mo. follow-up | 0 |
8,882 | 80.07098 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | >$50k | 0 | 54,121 | 36,237.0625 | 41,810.0938 | 63 | white | 36.09375 | 63 | 0.350952 | 0.234985 | 13 | 0 | 0 | no | null | null | no dnr | 4 | 120 | 7.299805 | 14 | 10 | 38.89844 | 129 | 3.699707 | 0.699951 | 0.5 | 137 | 7.40918 | 137 | 15 | 3,525 | null | 0 | <2 mo. follow-up | 0 |
8,883 | 61.03799 | 0 | male | 0 | 10 | 606 | COPD | COPD/CHF/Cirrhosis | 0 | 12 | null | 0 | 11,265 | 7,681.9844 | 8,306.57812 | 20.5 | white | 21 | 26 | 0.871948 | 0.786987 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 49 | 6.5 | 158 | 10 | 36.79688 | 136 | 2.199707 | 0.599976 | 1.599854 | 131 | 7.429688 | 78 | 12 | 2,875 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,884 | 82.71899 | 0 | female | 0 | 21 | 603 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | under $11k | 0 | 33,923 | 21,274.0625 | 23,252.1094 | 25 | white | 21.898438 | 36 | 0.775879 | 0.702881 | 1 | 0 | 1 | no | 0.8 | 0.8 | no dnr | 21 | 83 | 11.199219 | 101 | 28 | 39.09375 | null | null | null | 0.899902 | 138 | null | 130 | 6 | 3,175 | null | 6 | adl>=4 (>=5 if sur) | 6 |
8,885 | 50.00699 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | >$50k | 0 | 28,269 | 18,869.2031 | 20,516.5781 | 27 | white | 32.796875 | 34 | 0.719971 | 0.633911 | 1 | 0 | 0 | no | 0.49 | 0.49 | no dnr | 14 | 65 | 19 | 70 | 15 | 36.09375 | 108.15625 | 3.699707 | 0.699951 | 5.399414 | 126 | 7.479492 | 267 | 96 | 190 | null | 1 | <2 mo. follow-up | 1 |
8,886 | 69.59296 | 1 | male | 0 | 5 | 103 | Colon Cancer | Cancer | 1 | 8 | under $11k | 0 | 2,545 | 1,613.3086 | 1,731.61914 | 13 | white | 19.5 | 16 | 0.770996 | 0.523926 | 1 | 0 | 0 | metastatic | 0.2 | 0.05 | dnr after sadm | 3 | 111 | null | 62 | 16 | 36.39844 | null | null | null | null | 140 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.494751 |
8,887 | 74.05096 | 1 | female | 1 | 49 | 49 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | under $11k | 26 | 100,702 | 66,196.125 | 77,436.125 | 40 | white | 28.199219 | 31 | 0.455994 | 0.336975 | 4 | 0 | 0 | yes | 0.7 | 0.7 | dnr after sadm | 47 | 104 | 8.199219 | 79 | 24 | 35.5 | null | 3.899902 | 0.399963 | 0.799927 | 136 | null | 116 | 31 | 2,300 | null | 6 | <2 mo. follow-up | 6 |
8,888 | 64.58899 | 1 | female | 0 | 6 | 91 | Lung Cancer | Cancer | 1 | null | null | 0 | 7,143 | 4,358.4766 | 2,398.69922 | 10 | white | 15.798828 | 10 | 0.73291 | 0.462952 | 1 | 0 | 0 | metastatic | 1 | 0.51 | no dnr | 6 | 108 | 5.799805 | 114 | 16 | 36.19531 | null | null | null | null | 140 | null | null | null | null | null | null | null | 1.982178 |
8,889 | 81.41797 | 0 | male | 0 | 14 | 598 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 11,063 | 7,162.5781 | 5,944.11719 | 4.333332 | white | 13.5 | 23 | 0.881958 | 0.802979 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 14 | 71 | null | 57 | 20 | 35.89844 | 304.75 | 3.699707 | 1.199951 | 1.699951 | 135 | 7.519531 | 120 | 44 | null | 0 | 0 | null | 0 |
8,890 | 88.28699 | 1 | female | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | under $11k | 0 | 20,082 | 13,371.9375 | 15,769.0078 | 44 | white | 29.398438 | 49 | 0.593994 | 0.485962 | 1 | 0 | 0 | no | 0.1 | 0.1 | dnr after sadm | 1 | 61 | 3.699707 | 65 | 20 | 36.09375 | null | 4.099609 | 2 | 1.099854 | 132 | null | 176 | 35 | 850 | null | 0 | <2 mo. follow-up | 0 |
8,891 | 65.495 | 1 | male | 0 | 8 | 48 | CHF | COPD/CHF/Cirrhosis | 6 | 15 | under $11k | 0 | 5,817 | 3,923.6973 | 3,969.18945 | 5.5 | white | 20.398438 | 31 | 0.855957 | 0.762939 | 1 | 1 | 1 | no | null | null | no dnr | 8 | 64 | 11.298828 | 72 | 14 | 36.09375 | 157.5 | null | null | 1 | 141 | 7.419922 | 354 | 24 | 725 | 2 | 2 | <2 mo. follow-up | 2 |
8,892 | 69.65399 | 1 | female | 1 | 11 | 11 | Coma | Coma | 1 | null | null | 61 | 41,832 | 29,165.875 | 32,677.4688 | 27.5 | white | 34.898438 | 57 | 0.036995 | 0.017998 | 10 | 1 | 0 | no | null | null | no dnr | 11 | 77 | 10 | 57 | 28 | 35.79688 | null | 4.299805 | 1.399902 | 1.299805 | 136 | null | 271 | 21 | 1,695 | null | null | <2 mo. follow-up | 2.309082 |
8,893 | 75.96698 | 0 | female | 0 | 12 | 593 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 44 | 17,883 | 12,190.1406 | 12,751.8594 | 17 | white | 18.097656 | 21 | 0.710938 | 0.55188 | 1 | 1 | 1 | no | null | null | no dnr | 12 | 57 | 11.599609 | 101 | 28 | 36.39844 | 130 | 2.899902 | 0.299988 | 0.799927 | 137 | 7.399414 | 178 | 19 | 1,100 | null | 2 | no(M2 and SIP pres) | 2 |
8,894 | 69.58795 | 1 | female | 0 | 6 | 64 | Lung Cancer | Cancer | 3 | 9 | $11-$25k | 0 | 4,334 | 2,818.1992 | 3,109.70898 | 10 | white | 22.398438 | 14 | 0.571899 | 0.250977 | 1 | 1 | 0 | metastatic | 0.5 | 0.3 | no dnr | 6 | 59 | 18.097656 | 96 | 16 | 38.69531 | 127.5 | null | 0.199982 | 1.799805 | 139 | 7.5 | 222 | 36 | 2,631 | null | null | null | 2.578613 |
8,895 | 60.51999 | 1 | male | 0 | 7 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 10 | $25-$50k | 44 | 15,369 | 10,618.8906 | 12,286.6797 | 20 | white | 31.5 | 89 | 0.319946 | 0.136993 | 1 | 1 | 0 | no | 0.8 | 0.8 | dnr after sadm | 4 | 104 | 16.5 | 79 | 28 | 35.89844 | null | 4.699219 | 1.199951 | 1 | 134 | null | 104 | 17 | null | null | 0 | <2 mo. follow-up | 0 |
8,896 | 63.52597 | 1 | male | 0 | 61 | 173 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 44 | 195,557 | 77,800.1875 | 86,105.1875 | 34.75 | white | 23.398438 | 39 | 0.560913 | 0.448975 | 5 | 0 | 0 | yes | 0.3 | 0.3 | dnr after sadm | 15 | 67 | 12.5 | 100 | 20 | 36.09375 | null | 2.199707 | 6.699219 | 1.099854 | 131 | null | 105 | 18 | 1,900 | null | 0 | no(M2 and SIP pres) | 0 |
8,897 | 87.98596 | 0 | male | 0 | 10 | 590 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 6,883 | 4,599.7266 | 4,546.40625 | 8 | white | 18.5 | 27 | 0.695923 | 0.531982 | 1 | 0 | 0 | yes | 0.8 | 0.6 | no dnr | 10 | 109 | 15.099609 | 104 | 34 | 36.79688 | 309.5 | 3.899902 | 0.599976 | 1.099854 | 132 | 7.489258 | 123 | 13 | null | 3 | 1 | no(M2 and SIP pres) | 1 |
8,898 | 84.29297 | 1 | male | 0 | 17 | 156 | CHF | COPD/CHF/Cirrhosis | 5 | 8 | $25-$50k | 0 | 18,165 | 11,636.9922 | 12,352.8828 | 12.333328 | white | 32 | 57 | 0.546997 | 0.348999 | 1 | 1 | 0 | no | 0.6 | 0.4 | no dnr | 17 | 80 | 9.798828 | 68 | 24 | 38.69531 | 364 | null | 1.299805 | 1.099854 | 137 | 7.489258 | 184 | 26 | 1,775 | 0 | 1 | no(M2 and SIP pres) | 1 |
8,899 | 63.24399 | 0 | male | 0 | 12 | 587 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | $11-$25k | 0 | 16,650 | 10,887.9375 | 12,403.4766 | 25 | white | 23.5 | 43 | 0.819946 | 0.759888 | 1 | 0 | 0 | no | 0.75 | 0.65 | no dnr | 12 | 70 | 6.099609 | 73 | 22 | 36.29688 | null | 3.899902 | 0.799927 | 1.099854 | 132 | null | 111 | 14 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,900 | 67.06097 | 1 | male | 0 | 8 | 93 | Lung Cancer | Cancer | 2 | 8 | $11-$25k | 0 | 5,283 | 3,447.1289 | 3,774.14844 | 8.5 | white | 6.599609 | 25 | 0.859985 | 0.687988 | 1 | 0 | 0 | metastatic | 0.95 | 0.6 | no dnr | 8 | 57 | 25 | 120 | 26 | 39.09375 | 237.125 | 2.199707 | 0.799927 | 1.199951 | 138 | 7.399414 | 135 | 19 | 1,815 | 0 | 1 | no(M2 and SIP pres) | 1 |